Chronic ROS leads to H2AX poly-ubiquitination due to increased interaction between H2AX and E3 ubiquitin ligase RNF168, which results in reduced level of H2AX and increased sensitivity of cancer cells to chemotherapy (Gruosso et al., 2016). The gene discussed is H2AX; the disease is cancer.